Evemie Schutyser

3.3k citations

30 papers · 2.8k indexed · 1 hit paper · h-index 22

Co-authors: Jo Van Damme Sofie Struyf Paul Proost Ann Richmond Ghislain Opdenakker Mieke Gouwy Patricia Menten Willy Put
Topics: Chemokine receptors and signaling (27 papers)Immunotherapy and Immune Responses (11 papers)Glycosylation and Glycoproteins Research (9 papers)
Cited by: Immunology Immunology and Allergy Oncology
Journals: Journal of Biological Chemistry Journal of Clinical Investigation The Journal of Experimental Medicine
Partner nations: Belgium United States Netherlands

In The Last Decade

Evemie Schutyser

30 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The CC chemokine CCL20 and its receptor CCR6

2003 644 citations Evemie Schutyser, Sofie Struyf et al. Cytokine & Growth Factor Reviews profile →

Peers

Countries citing papers authored by Evemie Schutyser

Since Specialization

Citations

This map shows the geographic impact of Evemie Schutyser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evemie Schutyser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evemie Schutyser more than expected).

Fields of papers citing papers by Evemie Schutyser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evemie Schutyser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evemie Schutyser. The network helps show where Evemie Schutyser may publish in the future.

Co-authorship network of co-authors of Evemie Schutyser

This figure shows the co-authorship network connecting the top 25 collaborators of Evemie Schutyser. A scholar is included among the top collaborators of Evemie Schutyser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evemie Schutyser. Evemie Schutyser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Short And Long Term Costs Associated With Different Cardiovascular Events In Belgium 2016 ·Value in Health ·(unknown),Philippe Chévalier,(unknown),Lucie Kutikova,Evemie Schutyser,Lieven Annemans	2
2	CINACALCET FOR MANAGING SECONDARY HYPERPARATHYROIDISM IN DIALYSIS PATIENTS IN CLINICAL PRACTICE IN BELGIUM: A 16-MONTH OBSERVATIONAL STUDY (ECHO-B) 2013 ·Acta Clinica Belgica ·Frederic Debellé,Gert Meeus,Max Dratwa,Bart Maes,Raymond Vanholder,Anthony P. Albert,Evemie Schutyser,Michel Jadoul	2
3	Expression of angiostatic platelet factor-4var/CXCL4L1 counterbalances angiogenic impulses of vascular endothelial growth factor, interleukin-8/CXCL8, and stromal cell-derived factor 1/CXCL12 in esophageal and colorectal cancer 2010 ·Human Pathology ·Hannelien Verbeke,(unknown),Sandra Li,Jo Vandercappellen,Sam Noppen,Evemie Schutyser,(unknown),Ghislain Opdenakker,Jo Van Damme,Karel Geboes,Sofie Struyf	21
4	Carcinoma cell‐derived chemokines and their presence in oral fluid 2009 ·European Journal Of Oral Sciences ·(unknown),Evemie Schutyser,René Conings,Jean‐Pierre Lenaerts,Willy Put,Sandra Nuyts,Pierre Delaere,Reinhilde Jacobs,Sofie Struyf,Paul Proost,Jo Van Damme	27
5	Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation 2008 ·The Journal of Experimental Medicine ·Paul Proost,Tamara Loos,Anneleen Mortier,Evemie Schutyser,Mieke Gouwy,Sam Noppen,Chris Dillen,Isabelle Ronsse,René Conings,Sofie Struyf,Ghislain Opdenakker,Prabhat C. Maudgal,Jo Van Damme	149
6	Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation 2008 ·The Journal of Cell Biology ·Paul Proost,Tamara Loos,Anneleen Mortier,Evemie Schutyser,Mieke Gouwy,Sam Noppen,Chris Dillen,Isabelle Ronsse,René Conings,Sofie Struyf,Ghislain Opdenakker,Prabhat C. Maudgal,Jo Van Damme	4
7	Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration 2007 ·Blood ·Paul Proost,Anneleen Mortier,Tamara Loos,Jo Vandercappellen,Mieke Gouwy,Isabelle Ronsse,Evemie Schutyser,Willy Put,Marc Parmentier,Sofie Struyf,Jo Van Damme	113
8	Hypoxia enhances CXCR4 expression in human microvascular endothelial cells and human melanoma cells. 2007 ·PubMed ·Evemie Schutyser,Yingjun Su,Yingchun Yu,Mieke Gouwy,Snjezana Zaja‐Milatovic,Jo Van Damme,Ann Richmond	81
9	Deletion of the COOH-Terminal Domain of CXC Chemokine Receptor 4 Leads to the Down-regulation of Cell-to-Cell Contact, Enhanced Motility and Proliferation in Breast Carcinoma Cells 2006 ·Cancer Research ·Yukiko Ueda,Nicole F. Neel,Evemie Schutyser,Dayanidhi Raman,Ann Richmond	46
10	TLR ligands and cytokines induce CXCR3 ligands in endothelial cells: enhanced CXCL9 in autoimmune arthritis 2006 ·Laboratory Investigation ·Tamara Loos,(unknown),Sofie Struyf,Evemie Schutyser,Klara Gijsbers,Mieke Gouwy,(unknown),Willy Put,Isabelle Ronsse,Bernard Grillet,Ghislain Opdenakker,Jo Van Damme,Paul Proost	101
11	Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies 2006 ·Arthritis Research & Therapy ·Paul Proost,Sofie Struyf,Tamara Loos,Mieke Gouwy,Evemie Schutyser,René Conings,Isabelle Ronsse,Marc Parmentier,Bernard Grillet,Ghislain Opdenakker,Jan Balzarini,Jo Van Damme	59
12	Chemokine receptor internalization and intracellular trafficking 2005 ·Cytokine & Growth Factor Reviews ·Nicole F. Neel,Evemie Schutyser,Jiqing Sai,Guo-Huang Fan,Ann Richmond	185
13	Posttranslational Processing of Chemokines 2003 ·Humana Press eBooks ·Paul Proost,Frank Mahieu,Evemie Schutyser,Jo Van Damme	16
14	The CXC Chemokine GCP-2/CXCL6 Is Predominantly Induced in Mesenchymal Cells by Interleukin-1β and Is Down-Regulated by Interferon-γ: Comparison with Interleukin-8/CXCL8 2003 ·Laboratory Investigation ·Anja Wuyts,Sofie Struyf,Klara Gijsbers,Evemie Schutyser,Willy Put,René Conings,Jean‐Pierre Lenaerts,Karel Geboes,Ghislain Opdenakker,Patricia Menten,Paul Proost,Jo Van Damme	81
15	PARC/CCL18 Is a Plasma CC Chemokine with Increased Levels in Childhood Acute Lymphoblastic Leukemia 2003 ·American Journal Of Pathology ·Sofie Struyf,Evemie Schutyser,Mieke Gouwy,Klara Gijsbers,Paul Proost,Yves Benoît,Ghislain Opdenakker,Jo Van Damme,Geneviève Laureys	65
16	Identification of Biologically Active Chemokine Isoforms from Ascitic Fluid and Elevated Levels of CCL18/Pulmonary and Activation-regulated Chemokine in Ovarian Carcinoma 2002 ·Journal of Biological Chemistry ·Evemie Schutyser,Sofie Struyf,Paul Proost,Ghislain Opdenakker,Geneviève Laureys,Bruno Verhasselt,(unknown),(unknown),Alessandra Saccani,Paola Allavena,Alberto Mantovani,Jo Van Damme	173
17	Selective induction of CCL18/PARC by staphylococcal enterotoxins in mononuclear cells and enhanced levels in septic and rheumatoid arthritis 2001 ·European Journal of Immunology ·Evemie Schutyser,Sofie Struyf,Anja Wuyts,Willy Put,Karel Geboes,Bernard Grillet,Ghislain Opdenakker,Jo Van Damme	53
18	Regulated Production and Molecular Diversity of Human Liver and Activation-Regulated Chemokine/Macrophage Inflammatory Protein-3α from Normal and Transformed Cells 2000 ·The Journal of Immunology ·Evemie Schutyser,Sofie Struyf,Patricia Menten,Jean‐Pierre Lenaerts,René Conings,Willy Put,Anja Wuyts,Paul Proost,Jo Van Damme	72
19	Biochemical and Biological Characterization of Neutrophil Chemotactic Protein, a Novel Rabbit CXC Chemokine from Alveolar Macrophages 2000 ·Biochemistry ·Anja Wuyts,Evemie Schutyser,Patricia Menten,Sofie Struyf,(unknown),Hidde Bult,Ghislain Opdenakker,Paul Proost,Jo Van Damme	10
20	The LD78β isoform of MIP-1α is the most potent CCR5 agonist and HIV-1–inhibiting chemokine 1999 ·Journal of Clinical Investigation ·Patricia Menten,Sofie Struyf,Evemie Schutyser,Anja Wuyts,Erik De Clercq,Dominique Schols,Paul Proost,Jo Van Damme	83

About Evemie Schutyser

Evemie Schutyser is a scholar working on Immunology and Allergy, Oncology and Immunology, having authored 30 papers that have together received 2.8k indexed citations. Recurring topics across this work include Chemokine receptors and signaling (27 papers), Immunotherapy and Immune Responses (11 papers) and Glycosylation and Glycoproteins Research (9 papers). The work is most often cited by research in Immunology (1.6k citations), Immunology and Allergy (328 citations) and Oncology (1.4k citations). Evemie Schutyser has collaborated with scholars based in Belgium, United States and Netherlands. Frequent co-authors include Jo Van Damme, Sofie Struyf, Paul Proost, Ann Richmond, Ghislain Opdenakker, Mieke Gouwy, Patricia Menten, Willy Put, Nicole F. Neel and Anja Wuyts. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact